COR-170 is a selective inverse agonist of CB2 receptors. References: Lowin T, Pongratz G, Straub RH. The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. J Inflamm (Lond). 2016 May 5;13:15. doi: 10.1186/s12950-016-0114-7. eCollection 2016. PubMed PMID: 27158245; PubMed Central PMCID: PMC4858820.

纯度：≥98%

CAS：1048039-15-1